Pfizer delayed the announcement of its COVID-19 vaccine until after the 2020 election when it thought Donald Trump was defeated.

Moderna stock dips 10% amid FDA resignation, signaling regulatory risks. Strong cash reserves can't offset competitive and ...

Shares of Moderna and other vaccine makers dropped Monday after the Food and Drug Administration's vaccine chief, Peter Marks, said he would resign, citing conflicts with Health and Human Services ...

Preparations are underway for a limited spring COVID-19 vaccination program in Alberta. Pharmacists have been told certain ...

Shares in Moderna, Vaxcyte, Novavax and BioNTech all fell Monday after Peter Marks, head of the FDA office that reviews ...

By Manas Mishra (Reuters) -Shares of U.S. drugmakers fell before the bell on Monday after reports that the Food and Drug ...

Shares of vaccine companies dropped after the Food and Drug Administration's top vaccine official was pushed out in a clash with Health and Human Services Secretary Robert F. Kennedy Jr.

U.S. drugmaker shares fell after the FDA's top vaccine official, Peter Marks, was forced to resign. Concerns grow over ...

Investing.com -- Moderna (NASDAQ: MRNA) shares dropped 13% pre-open on Monday as investors reacted to the weekend news that the U.S. Food and Drug Administration’s (FDA) top vaccine official, Dr.

Shares of Moderna, Novavax and other biotech companies fell after FDA official Peter Marks’s resignation in protest of Robert ...

Researchers at the University of Cologne have found that mRNA-based COVID-19 vaccines have a lasting impact on the innate ...

The report said Pfizer significantly lowered its tax bill by routing profits through Ireland and other jurisdictions.